Tellus BioVentures logo

Tellus BioVentures

North America, New York, United States, Florida

Description

Tellus BioVentures is a biotechnology investment fund focused on early-stage innovation and company formation.

Investor Profile

Tellus BioVentures has made 12 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (33%)
  • Series A (33%)
  • Series Unknown (17%)
  • Series B (8%)
  • Post Ipo Equity (8%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Therapeutics
  • Bioinformatics
  • Test And Measurement
  • Pharmaceutical
  • Medical
  • Life Science
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Tellus BioVentures frequently co-invest with?

The Mark Foundation for Cancer Research
North America, New York, United States, New York
Co-Investments: 2
Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Agent Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 2
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Fairmount Funds Management
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 5
Quan Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 3
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 2
Penn Medicine Co-Investment Program
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 3
University of Pennsylvania
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 2

Which angels does Tellus BioVentures often collaborate with?

BA
North America, Maryland, United States, Baltimore
Shared Deals: 1

What are some of recent deals done by Tellus BioVentures?

Dianthus Therapeutics

Waltham, Massachusetts, United States

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

BiopharmaBiotechnologyHealth Care
Post Ipo EquityJan 22, 2024
Amount Raised: $230,000,000
Cantai Therapeutics

Philadelphia, Pennsylvania, United States

Cantai Therapeutics operates as a developer of drug candidates.

Life ScienceMedical
SeedNov 20, 2023
Amount Raised: $700,000
Vittoria Biotherapeutics

Philadelphia, Pennsylvania, United States

Vittoria Biotherapeutics is a gene-edited cell therapeutics company.

BioinformaticsBiotechnologyTest and Measurement
Series UnknownNov 14, 2023
Amount Raised: $15,000,000
Praeventix

Exton, Pennsylvania, United States

Praeventix is a biotechnology company developing therapeutics to treat bowel diseases.

BiotechnologyHealth CareMedicalTherapeutics
Series UnknownNov 8, 2022
Amount Raised: $4,320,446
Zenas BioPharma

Waltham, Massachusetts, United States

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

BiopharmaHealth CarePharmaceutical
Series BNov 7, 2022
Amount Raised: $118,000,000
Vittoria Biotherapeutics

Philadelphia, Pennsylvania, United States

Vittoria Biotherapeutics is a gene-edited cell therapeutics company.

BioinformaticsBiotechnologyTest and Measurement
SeedJun 7, 2022
Amount Raised: $10,000,000
Dianthus Therapeutics

Waltham, Massachusetts, United States

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

BiopharmaBiotechnologyHealth Care
Series AApr 19, 2022
Amount Raised: $100,000,000
Interius BioTherapeutics

Philadelphia, Pennsylvania, United States

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

BiopharmaBiotechnologyHealth CareTherapeutics
Series AMay 18, 2021
Amount Raised: $76,000,000
Zenas BioPharma

Waltham, Massachusetts, United States

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

BiopharmaHealth CarePharmaceutical
Series AMar 23, 2021
TamuroBio

Mclean, Virginia, United States

TamuroBio is an operator of a biotechnology company intended to develop novel therapeutics for NAFLD/NASH and Type 2 diabetes.

Biotechnology
SeedJan 1, 2021